Health

Washington — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men. Currently, …

Boston — For every patient discharged from the pediatric intensive care unit at Mass General for Children in Boston, three more are waiting for that bed. A surge in cases of respiratory syncytial virus, also known as RSV, has hospitals nationwide struggling to treat patients.  “I’ve never seen, in my 26 …